Bone mineral density and intervertebral disc height in type 2 diabetes

Area of Science:

• Endocrinology
• Orthopedics
• Metabolic Diseases

Background:

• Conflicting results exist regarding type 2 diabetes (T2D) effects on bone mineral density (BMD).
• T2D is consistently linked to higher fracture risk, suggesting other contributing factors.
• Potential confounding factors may explain discrepancies in T2D and BMD research.

Purpose of the Study:

• To assess the relationship between T2D and BMD at the femoral neck and spine.
• To investigate intervertebral disc height in relation to fracture risk in T2D patients.
• To adjust for multiple covariates influencing BMD and fracture risk.

Main Methods:

• Cross-sectional study design.
• Inclusion of 100 T2D patients (duration ≥ 5 years) and 86 non-diabetic controls.
• Adjustment for potential confounding variables affecting BMD.

Main Results:

• No significant differences in spinal or femoral neck T scores between T2D and control groups after adjustments.
• Diabetic patients exhibited significantly lower intervertebral disc height (L2-L3) post-adjustment (p=0.004).
• Urinary albumin:creatinine ratio, total cholesterol, LDL-cholesterol, and smoking independently associated with lower disc height in T2D.

Conclusions:

• T2D shows no significant independent association with BMD.
• A novel association between T2D and reduced intervertebral disc height was identified.
• Lower disc height in T2D may contribute to increased vertebral fracture risk, warranting further investigation.